{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:20:25Z","timestamp":1793193625298,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Pain"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ynpai.2022.100094","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T17:51:03Z","timestamp":1654797063000},"page":"100094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Neurobiology of migraine progression"],"prefix":"10.1016","volume":"12","author":[{"given":"Wanakorn","family":"Rattanawong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Srikiatkhachorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ynpai.2022.100094_b0005","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/0333102414552532","article-title":"The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results","volume":"35","author":"Adams","year":"2015","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s10266-018-0360-7","article-title":"Association between periodontitis and chronic migraine: a case-control study","volume":"107","author":"Ameijeira","year":"2019","journal-title":"Odontology"},{"issue":"12","key":"10.1016\/j.ynpai.2022.100094_b0015","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1074\/mcp.RA119.001767","article-title":"PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models","volume":"18","author":"Anapindi","year":"2019","journal-title":"Mol. Cell. Proteomics: MCP"},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.pain.2010.11.007","article-title":"Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain","volume":"152","author":"Anderson","year":"2011","journal-title":"Pain"},{"issue":"6 Pt 1","key":"10.1016\/j.ynpai.2022.100094_b0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1006\/nimg.2000.0582","article-title":"Voxel-based morphometry\u2013the methods","volume":"11","author":"Ashburner","year":"2000","journal-title":"NeuroImage"},{"issue":"8","key":"10.1016\/j.ynpai.2022.100094_b0030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0333102409357958","article-title":"Headache characteristics and chronification of migraine and tension-type headache: A population-based study","volume":"30","author":"Ashina","year":"2010","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.ynpai.2022.100094_b0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10194-012-0479-9","article-title":"Depression and risk of transformation of episodic to chronic migraine","volume":"13","author":"Ashina","year":"2012","journal-title":"J. Headache Pain"},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1468-2982.2006.01255.x","article-title":"Identifying cutaneous allodynia in chronic migraine using a practical clinical method","volume":"27","author":"Ashkenazi","year":"2007","journal-title":"Cephalalgia"},{"issue":"5 Suppl","key":"10.1016\/j.ynpai.2022.100094_b0045","first-page":"S8","article-title":"Spectrum of illness: understanding biological patterns and relationships in chronic migraine","volume":"72","author":"Aurora","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ynpai.2022.100094_b0050","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1526-4610.2007.00853.x","article-title":"Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies","volume":"47","author":"Aurora","year":"2007","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/head.12999","article-title":"Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies","volume":"57","author":"Aurora","year":"2017","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10194-008-0019-9","article-title":"Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptans","volume":"9","author":"Ayzenberg","year":"2008","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.ynpai.2022.100094_b0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2017.02.001","article-title":"Brain network alterations in the inflammatory soup animal model of migraine","volume":"1660","author":"Becerra","year":"2017","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11916-006-0047-6","article-title":"Migraine at all ages","volume":"10","author":"Bigal","year":"2006","journal-title":"Curr. Pain Headache Rep."},{"issue":"11","key":"10.1016\/j.ynpai.2022.100094_b0075","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.wnl.0000325565.63526.d2","article-title":"Clinical course in migraine: conceptualizing migraine transformation","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/WCO.0b013e328300c6f5","article-title":"The prognosis of migraine","volume":"21","author":"Bigal","year":"2008","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.ynpai.2022.100094_b0090","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0333102415588328","article-title":"Volumetric differences suggest involvement of cerebellum and brainstem in chronic migraine","volume":"36","author":"Bilgi\u00e7","year":"2016","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0333102410381145","article-title":"Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)","volume":"31","author":"Blumenfeld","year":"2011","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0105","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/s41467-019-12197-3","article-title":"Maladaptive activation of Nav1.9 channels by nitric oxide causes triptan-induced medication overuse headache","volume":"10","author":"Bonnet","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.54.2.308","article-title":"Headache and major depression: is the association specific to migraine?","volume":"54","author":"Breslau","year":"2000","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.ynpai.2022.100094_b0115","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple processes, complex pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0120","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jnnp.2009.192492","article-title":"Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers","volume":"81","author":"Buse","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/head.13435","article-title":"Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study","volume":"59","author":"Buse","year":"2019","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10194-020-1084-y","article-title":"Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study","volume":"21","author":"Buse","year":"2020","journal-title":"J. Headache Pain"},{"issue":"8","key":"10.1016\/j.ynpai.2022.100094_b0135","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1526-4610.2009.01608.x","article-title":"The prevalence of neck pain in migraine","volume":"50","author":"Calhoun","year":"2010","journal-title":"Headache"},{"issue":"14","key":"10.1016\/j.ynpai.2022.100094_b0140","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","article-title":"Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine","volume":"81","author":"Cernuda-Moroll\u00f3n","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ynpai.2022.100094_b0145","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/head.12372","article-title":"CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine","volume":"54","author":"Cernuda-Moroll\u00f3n","year":"2014","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0333102419877171","article-title":"Proposed new diagnostic criteria for chronic migraine","volume":"40","author":"Chalmer","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ynpai.2022.100094_b0155","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fneur.2019.00606","article-title":"Volume of Hypothalamus as a Diagnostic Biomarker of Chronic Migraine","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10194-012-0447-4","article-title":"Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan","volume":"13","author":"Chen","year":"2012","journal-title":"J. Headache Pain"},{"issue":"Suppl 1","key":"10.1016\/j.ynpai.2022.100094_b0165","doi-asserted-by":"crossref","first-page":"A26","DOI":"10.1186\/1129-2377-16-S1-A26","article-title":"Neural plasticity and migraine","volume":"16","author":"Coppola","year":"2015","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1129-2377-14-65","article-title":"Habituation and sensitization in primary headaches","volume":"14","author":"Coppola","year":"2013","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1129-2377-14-76","article-title":"Electrophysiological correlates of episodic migraine chronification: evidence for thalamic involvement","volume":"14","author":"Coppola","year":"2013","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s10194-017-0825-z","article-title":"Cerebral gray matter volume in patients with chronic migraine: correlations with clinical features","volume":"18","author":"Coppola","year":"2017","journal-title":"J. Headache Pain"},{"issue":"11","key":"10.1016\/j.ynpai.2022.100094_b0185","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1093\/brain\/awx228","article-title":"Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis","volume":"140","author":"Datta","year":"2017","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.21897","article-title":"Triptan-induced latent sensitization: a possible basis for medication overuse headache","volume":"67","author":"De Felice","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.ynpai.2022.100094_b0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3959(02)00299-3","article-title":"Abnormal brain processing of cutaneous pain in patients with chronic migraine","volume":"101","author":"de Tommaso","year":"2003","journal-title":"Pain"},{"issue":"Pt 3","key":"10.1016\/j.ynpai.2022.100094_b0200","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/awl351","article-title":"Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine?","volume":"130","author":"Di Clemente","year":"2007","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/head.14036","article-title":"Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2","volume":"61","author":"Diener","year":"2021","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-2982.2004.00647.x","article-title":"Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain","volume":"24","author":"Dobson","year":"2004","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"10.1016\/j.ynpai.2022.100094_b0215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A phase-by-phase review of migraine pathophysiology","volume":"58","author":"Dodick","year":"2018","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0220","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0333102420966658","article-title":"Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine","volume":"41","author":"Dodick","year":"2021","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ynpai.2022.100094_b0225","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez, C., L\u00f3pez, A., Ramos-Cabrer, P., Vieites-Prado, A., P\u00e9rez-Mato, M., Villalba, C., Sobrino, T., Rodriguez-Osorio, X., Campos, F., Castillo, J., & Leira, R., 2019. Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.Neurology,92(10), e1076\u2013e1085.","DOI":"10.1212\/WNL.0000000000007047"},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0230","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0333102417720213","article-title":"Role of adipocytokines in the pathophysiology of migraine: a cross-sectional study","volume":"38","author":"Dom\u00ednguez","year":"2018","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.ynpai.2022.100094_b0235","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","article-title":"Does inflammation have a role in migraine?","volume":"15","author":"Edvinsson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.ynpai.2022.100094_b0240","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ajpath.2021.02.007","article-title":"White Matter Lesions in Migraine","volume":"191","author":"Eikermann-Haerter","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ynpai.2022.100094_b0250","doi-asserted-by":"crossref","unstructured":"Han, L., Liu, Y., Xiong, H., & Hong, P., 2019. CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta-analysis.Brain and behavior,9(2), e01215.","DOI":"10.1002\/brb3.1215"},{"key":"10.1016\/j.ynpai.2022.100094_b0255","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. (2018).Cephalalgia : an international journal of headache,38(1), 1\u2013211.","DOI":"10.1177\/0333102417738202"},{"issue":"7","key":"10.1016\/j.ynpai.2022.100094_b0260","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/head.14154","article-title":"Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency","volume":"61","author":"Ishii","year":"2021","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0265","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","article-title":"The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine","volume":"158","author":"Iyengar","year":"2017","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/head.13529","article-title":"CGRP and the Trigeminal System in Migraine","volume":"59","author":"Iyengar","year":"2019","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1601-0825.2010.01717.x","article-title":"Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients","volume":"17","author":"Jang","year":"2011","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1965.sp007742","article-title":"Heterosynaptic facilitation in neurones of the abdominal ganglion of Aplysia depilans","volume":"181","author":"Kandel","year":"1965","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0285","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0333102413505238","article-title":"Psychiatric comorbidities in allodynic migraineurs","volume":"34","author":"Kao","year":"2014","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0290","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","article-title":"Defining the differences between episodic migraine and chronic migraine","volume":"16","author":"Katsarava","year":"2012","journal-title":"Curr. Pain Headache Rep."},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0295","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2010.03.042","article-title":"Intrinsic functional connectivity of the periaqueductal gray, a resting fMRI study","volume":"211","author":"Kong","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.ynpai.2022.100094_b0300","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/0333102416650702","article-title":"Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents","volume":"37","author":"Kopruszinski","year":"2017","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0305","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1468-2982.1995.015002123.x","article-title":"Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack","volume":"15","author":"Kropp","year":"1995","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0310","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.291.4.427","article-title":"Migraine as a risk factor for subclinical brain lesions","volume":"291","author":"Kruit","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-2982.2009.01904.x","article-title":"Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study","volume":"30","author":"Kruit","year":"2010","journal-title":"Cephalalgia"},{"issue":"14","key":"10.1016\/j.ynpai.2022.100094_b0320","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1177\/0333102416630593","article-title":"Gray matter changes related to medication overuse in patients with chronic migraine","volume":"36","author":"Lai","year":"2016","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.ynpai.2022.100094_b0325","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J. Pain"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s10194-019-0986-z","article-title":"Increased connectivity of pain matrix in chronic migraine: a resting-state functional MRI study","volume":"20","author":"Lee","year":"2019","journal-title":"J. Headache Pain"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0335","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cne.21607","article-title":"Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution","volume":"507","author":"Lennerz","year":"2008","journal-title":"J. Comp. Neurol."},{"issue":"7","key":"10.1016\/j.ynpai.2022.100094_b0340","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0333102419833087","article-title":"Functional connectivity of hypothalamus in chronic migraine with medication overuse","volume":"39","author":"Lerebours","year":"2019","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0350","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0355","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.21211","article-title":"Cutaneous allodynia in the migraine population","volume":"63","author":"Lipton","year":"2008","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0360","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1526-4610.2012.02292.x","article-title":"Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study","volume":"53","author":"Lipton","year":"2013","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0365","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/head.12332","article-title":"Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study","volume":"54","author":"Lipton","year":"2014","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.ynpai.2022.100094_b0370","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/head.13997","article-title":"Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study","volume":"60","author":"Lipton","year":"2020","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0375","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0333102420973994","article-title":"Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension","volume":"41","author":"Lipton","year":"2021","journal-title":"Cephalalgia"},{"issue":"14","key":"10.1016\/j.ynpai.2022.100094_b0380","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1177\/0333102416678624","article-title":"Hippocampus and amygdala volume in relation to migraine frequency and prognosis","volume":"37","author":"Liu","year":"2017","journal-title":"Cephalalgia"},{"issue":"Pt 11","key":"10.1016\/j.ynpai.2022.100094_b0385","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1093\/brain\/awt251","article-title":"Cutaneous allodynia as a predictor of migraine chronification","volume":"136","author":"Louter","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0390","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0306-4522(00)00226-8","article-title":"Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons","volume":"99","author":"Ma","year":"2000","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0395","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.22537","article-title":"Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine","volume":"70","author":"Mainero","year":"2011","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.ynpai.2022.100094_b0400","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1212\/WNL.0b013e31820d8af2","article-title":"Rates, predictors, and consequences of remission from chronic migraine to episodic migraine","volume":"76","author":"Manack","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0405","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11916-013-0333-z","article-title":"Functional imaging in chronic migraine","volume":"17","author":"Maniyar","year":"2013","journal-title":"Curr. Pain Headache Rep."},{"issue":"Pt 1","key":"10.1016\/j.ynpai.2022.100094_b0410","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/brain\/awh022","article-title":"Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study","volume":"127","author":"Matharu","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.ynpai.2022.100094_b0415","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/JPR.S103238","article-title":"A touchy subject: an assessment of cutaneous allodynia in a chronic migraine population","volume":"9","author":"Mathew","year":"2016","journal-title":"J. Pain Res."},{"issue":"8","key":"10.1016\/j.ynpai.2022.100094_b0420","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","article-title":"Chronic migraine: risk factors, mechanisms and treatment","volume":"12","author":"May","year":"2016","journal-title":"Nature Rev. Neurol."},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0425","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-020-02161-7","article-title":"Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators","volume":"127","author":"Messlinger","year":"2020","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0430","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s10194-021-01216-8","article-title":"Structural brain network characteristics in patients with episodic and chronic migraine","volume":"22","author":"Michels","year":"2021","journal-title":"J. Headache Pain"},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0435","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0333102418804157","article-title":"Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache","volume":"39","author":"Nation","year":"2019","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0440","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/head.13012","article-title":"Structural gray matter alterations in chronic migraine: implications for a progressive disease?","volume":"57","author":"Neeb","year":"2017","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0445","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41983-018-0027-x","article-title":"Relation between migraine pattern and white matter hyperintensities in brain magnetic resonance imaging","volume":"54","author":"Negm","year":"2018","journal-title":"Egypt. J. Neurol., Psychiatry Neurosurg."},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0450","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s10194-019-1068-y","article-title":"Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level heada-che Centre","volume":"20","author":"Negro","year":"2019","journal-title":"J. Headache Pain"},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0455","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/brain\/awx331","article-title":"Neurochemical changes in the medial wall of the brain in chronic migraine","volume":"141","author":"Niddam","year":"2018","journal-title":"Brain"},{"issue":"50","key":"10.1016\/j.ynpai.2022.100094_b0460","doi-asserted-by":"crossref","first-page":"15828","DOI":"10.1523\/JNEUROSCI.3623-09.2009","article-title":"Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons","volume":"29","author":"Okada-Ogawa","year":"2009","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.ynpai.2022.100094_b0465","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ana.410280610","article-title":"Timing and topography of cerebral blood flow, aura, and headache during migraine attacks","volume":"28","author":"Olesen","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ynpai.2022.100094_b0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s10194-015-0510-z","article-title":"Migraine and body mass index categories: a systematic review and meta-analysis of observational studies","volume":"16","author":"Ornello","year":"2015","journal-title":"J. Headache Pain"},{"issue":"18","key":"10.1016\/j.ynpai.2022.100094_b0475","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2012.14276","article-title":"Structural brain changes in migraine","volume":"308","author":"Palm-Meinders","year":"2012","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ynpai.2022.100094_b0480","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1007\/s11033-020-05781-0","article-title":"Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice","volume":"47","author":"P\u00e9rez-Pereda","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ynpai.2022.100094_b0485","doi-asserted-by":"crossref","unstructured":"Peterlin, B. L., Sacco, S., Bernecker, C., & Scher, A. I., 2016. Adipokines and Migraine: A Systematic Review.Headache,56(4), 622\u2013644.","DOI":"10.1111\/head.12788"},{"key":"10.1016\/j.ynpai.2022.100094_b0490","doi-asserted-by":"crossref","unstructured":"Pinheiro, C. F., Moreira, J. R., Carvalho, G. F., Zorzin, L., Dach, F., & Bevilaqua-Grossi, D., 2021. Interictal Photophobia and Phonophobia Are Related to the Presence of Aura and High Frequency of Attacks in Patients with Migraine.Applied Sciences,11(6), 2474. MDPI AG.","DOI":"10.3390\/app11062474"},{"issue":"6","key":"10.1016\/j.ynpai.2022.100094_b0495","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1526-4610.2012.02155.x","article-title":"Self-reported comorbid pains in severe headaches or migraines in a US national sample","volume":"52","author":"Plesh","year":"2012","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0500","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12868-019-0536-2","article-title":"Altered activity in the nucleus raphe magnus underlies cortical hyperexcitability and facilitates trigeminal nociception in a rat model of medication overuse headache","volume":"20","author":"Potewiratnanond","year":"2019","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0505","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/head.12450","article-title":"Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results","volume":"55","author":"Reed","year":"2015","journal-title":"Headache"},{"issue":"1\u20132","key":"10.1016\/j.ynpai.2022.100094_b0510","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3959(03)00293-8","article-title":"Factors associated with the onset and remission of chronic daily headache in a population-based study","volume":"106","author":"Scher","year":"2003","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.ynpai.2022.100094_b0515","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1212\/01.WNL.0000145760.37852.ED","article-title":"Caffeine as a risk factor for chronic daily headache: a population-based study","volume":"63","author":"Scher","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0520","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pain.2010.12.002","article-title":"Is chronic migraine a never-ending migraine attack?","volume":"152","author":"Schoenen","year":"2011","journal-title":"Pain"},{"issue":"21","key":"10.1016\/j.ynpai.2022.100094_b0525","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1212\/WNL.0000000000003963","article-title":"Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI","volume":"88","author":"Schulte","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0530","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10194-017-0787-1","article-title":"Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design","volume":"18","author":"Serrano","year":"2017","journal-title":"J. Headache Pain"},{"issue":"9","key":"10.1016\/j.ynpai.2022.100094_b0535","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1046\/j.1526-4610.2002.02217.x","article-title":"Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application","volume":"42","author":"Sheftell","year":"2002","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0540","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1468-2982.2006.01275.x","article-title":"Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study","volume":"27","author":"Silberstein","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ynpai.2022.100094_b0545","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s10194-016-0637-6","article-title":"Differences in central facilitation between episodic and chronic migraineurs in nociceptive-specific trigeminal pathways","volume":"17","author":"Sohn","year":"2016","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.ynpai.2022.100094_b0550","doi-asserted-by":"crossref","unstructured":"Su, M., & Yu, S., 2018. Chronic migraine: A process of dysmodulation and sensitization.Molecular pain,14, 1744806918767697.","DOI":"10.1177\/1744806918767697"},{"issue":"4","key":"10.1016\/j.ynpai.2022.100094_b0555","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/ejn.13296","article-title":"Rizatriptan overuse promotes hyperalgesia induced by dural inflammatory stimulation in rats by modulation of the serotonin system","volume":"44","author":"Su","year":"2016","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0560","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40263-021-00818-9","article-title":"The Evolution of Medication Overuse Headache: History. Pathophysiology and Clinical Update","volume":"35","author":"Sun-Edelstein","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0565","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1526-4610.2006.00310.x","article-title":"Serotonin depletion, cortical spreading depression, and trigeminal nociception","volume":"46","author":"Supornsilpchai","year":"2006","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.ynpai.2022.100094_b0570","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0333102409355600","article-title":"Cortical hyperexcitability and mechanism of medication-overuse headache","volume":"30","author":"Supornsilpchai","year":"2010","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.ynpai.2022.100094_b0575","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archneur.61.9.1366","article-title":"Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis","volume":"61","author":"Swartz","year":"2004","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.ynpai.2022.100094_b0580","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0333102416636055","article-title":"When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month","volume":"37","author":"Torres-Ferr\u00fas","year":"2017","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0585","first-page":"1","article-title":"Blink reflex in migraine headache","volume":"3","author":"Unal","year":"2016","journal-title":"Northern Clin. Istanbul"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0590","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1526-4610.2007.00723.x","article-title":"Voxel-based morphometry reveals gray matter abnormalities in migraine","volume":"48","author":"Valfr\u00e8","year":"2008","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0595","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0333102415625614","article-title":"Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis","volume":"37","author":"Van Dongen","year":"2017","journal-title":"Cephalalgia"},{"issue":"14","key":"10.1016\/j.ynpai.2022.100094_b0600","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1177\/0333102418761047","article-title":"Factors associated to chronic migraine with medication overuse: A cross-sectional study","volume":"38","author":"Viana","year":"2018","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.ynpai.2022.100094_b0605","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nm0795-658","article-title":"Brain stem activation in spontaneous human migraine attacks","volume":"1","author":"Weiller","year":"1995","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.ynpai.2022.100094_b0610","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1526-4610.2001.041007629.x","article-title":"Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?","volume":"41","author":"Welch","year":"2001","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.ynpai.2022.100094_b0615","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/0333102419883355","article-title":"Predictors of episodic migraine transformation to chronic migraine: A systematic review and meta-analysis of observational cohort studies","volume":"40","author":"Xu","year":"2020","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.ynpai.2022.100094_b0620","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12031-020-01683-9","article-title":"Searching for Predictors of Migraine Chronification: a Pilot Study of 1911A>G Polymorphism of TRPV1 Gene in Episodic Versus Chronic Migraine","volume":"71","author":"Yakubova","year":"2021","journal-title":"J. Mol. Neurosci.: MN"},{"issue":"1","key":"10.1016\/j.ynpai.2022.100094_b0625","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s10194-017-0736-z","article-title":"Depression and anxiety behaviour in a rat model of chronic migraine","volume":"18","author":"Zhang","year":"2017","journal-title":"J. Headache Pain"},{"issue":"30","key":"10.1016\/j.ynpai.2022.100094_b0630","doi-asserted-by":"crossref","first-page":"25073","DOI":"10.1074\/jbc.M112.378737","article-title":"Chronic opioid potentiates presynaptic but impairs postsynaptic N-methyl-D-aspartic acid receptor activity in spinal cords: implications for opioid hyperalgesia and tolerance","volume":"287","author":"Zhao","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Neurobiology of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452073X22000113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452073X22000113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:26:32Z","timestamp":1762529192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452073X22000113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":124,"alternative-id":["S2452073X22000113"],"URL":"https:\/\/doi.org\/10.1016\/j.ynpai.2022.100094","relation":{},"ISSN":["2452-073X"],"issn-type":[{"value":"2452-073X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurobiology of migraine progression","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ynpai.2022.100094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100094"}}